In this special Science and U interview, Professor Michael Lisanti, Chair of Translational Medicine at the University of Salford, returns to speak with David Gornoski, Tucker Goodrich, and Dr. Weiping Yu. The conversation centers around Dr. Lisanti's fascinating method of fighting metastatic cancer cells with antibiotics like Doxycycline and Bedaquiline. How does Dr. Lisanti's way of treating cancer differ from the common approach and why is it so groundbreaking? How does this approach turn off ATP production without the toxicity associated with the general approach? Listen to the full podcast to find out.
Read Prof. Lisanti's Nature paper here. Read Tucker Goodrich’s fascinating blog here. For more content by David Gornoski visit aneighborschoice.com
David Gornoski